Exponent vs Hackett
EXPO and HCKT side by side, both in management and public relations services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EXPO and HCKT compare
Exponent is the larger company, worth 13 times as much as Hackett ($4.2B against $326M).
On earnings, Hackett is cheaper: it trades at 20.2× trailing earnings, against 39.3× for Exponent.
Exponent grew revenue faster over the last twelve months (12.8% versus −9.1% for Hackett).
Exponent keeps more of each dollar of sales as profit, with a net margin of 17.7% compared with 5.9% at Hackett.
Both pay dividends: Exponent yields 1.4% and Hackett 3.7%.
Exponent scores higher on the StockData Score (20 against 17 for Hackett), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EXPO | HCKT |
|---|---|---|
| Size and price | ||
| Market cap | $4.2B | $326M |
| Share price | $87.69 | $13.11 |
| Change, 1 year | 25.4% | −28.9% |
| Change, 5 years | −24.9% | −38.0% |
| Beta (5Y) | 0.24 | 0.48 |
| Employees | 1,313 | 1,503 |
| StockData Score | ||
| Total score | 20 (better) | 17 |
| Valuation score | 2 | 3 (better) |
| Growth score | 3 (better) | 1 |
| Performance score | 5 | 5 |
| Health score | 6 (better) | 4 |
| Dividend score | 4 | 4 |
| Valuation | ||
| P/E | 39.3× | 20.2× (better) |
| P/S | 6.6× | 1.1× (better) |
| P/B | 14.4× | 4.8× (better) |
| EV/EBITDA | 29.8× | 12.6× (better) |
| P/FCF | 38.4× | 10.5× (better) |
| PEG | 21.41 | – |
| FCF yield | 2.6% | 9.6% (better) |
| Fair value | $66.46 | $14.46 |
| Margin of safety | −31.9% | 9.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 12.8% (better) | −9.1% |
| Revenue growth, 5Y average | 7.8% (better) | 5.0% |
| Net income growth (TTM) | 8.7% (better) | −0.74% |
| EPS growth (TTM) | 11.5% (better) | 8.3% |
| EPS growth, 5Y average | 6.0% | 22.0% (better) |
| Profitability | ||
| Gross margin | – | 41.3% |
| Operating margin | 20.2% (better) | 10.9% |
| Net margin | 17.7% (better) | 5.9% |
| FCF margin | 17.2% (better) | 10.9% |
| Return on equity | 31.2% (better) | 17.9% |
| Return on invested capital | 43.8% (better) | 14.1% |
| Financial health | ||
| Debt / equity | 0.00 | 1.19 (better) |
| Net debt / EBITDA | – | 2.14 |
| Interest coverage | – | 9.3× |
| Current ratio | 1.98 (better) | 1.94 |
| Altman Z-score | 10.26 (better) | 4.04 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.4% | 3.7% (better) |
| Payout ratio | 54.8% | 74.8% |
| Years of dividend growth | 13 (better) | 0 |
| Dividend growth, 5Y average | 9.6% (better) | 4.8% |
| Buyback yield | 5.1% | 20.1% (better) |
| Shareholder yield | 6.5% | 23.8% (better) |
| Ownership | ||
| Held by institutions | 97.8% | 84.5% |
| Held by insiders | 1.3% | 12.6% |
| Insider net buying, 12 months | −$2.7M | – |
| Short interest, % of float | 5.2% | 5.6% |
Go deeper
- EXPO stock overview
- EXPO income statement
- EXPO valuation and score
- HCKT stock overview
- HCKT income statement
- HCKT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.